2025 fourth_quarter Filing
Q4Income
$75K
Filed
February 8, 2026
Lobbying Activities
AnimalsView all
The main objective is to highlight the business activities of Kiril & Georgi Domuschiev in the US & Europe. The focus is on Huvepharma, one of the largest animal pharmaceutical companies in the US. This is a direct result of their FDI into the US over 20 years ago. It's the largest foreign investment into the US from Bulgaria. We are raising awareness in the US Congress, the State Department, Commerce and other US Government agencies about the strategic importance for the US of Huvepharma.
Contacted:Commerce, Dept of (DOC)
Lobbyists (1)
PHILIP BAY